doi:10.19983/j.issn.2096-8493.20230043

Abstract

CLC Number:

R521
R81

Figures/Tables 5

References 19

[1]	刘虎, 李承鑫. 儿童颈椎后凸畸形的手术治疗. 临床小儿外科杂志, 2021, 20(7):673-676. doi:10.12260/icxewkzz2021.07.015. doi: 10.12260/icxewkzz2021.07.015
[2]	张宏其, 刘少华. 儿童脊柱结核的治疗. 中华骨科杂志, 2014, 34(2):240-249. doi:10.3760/cma.j.issn.0253-2352.2014.02.022. doi: 10.3760/cma.j.issn.0253-2352.2014.02.022
[3]	王太平, 胥勇, 刘信, 等. 后路多椎体截骨矫形术治疗儿童胸椎结核伴脊柱后凸畸形1例. 中国骨与关节损伤杂志, 2021, 36(1):83-85. doi:10.7531/j.issn.1672-9935.2021.01.029. doi: 10.7531/j.issn.1672-9935.2021.01.029
[4]	万超敏, 申阿东, 刘芳. 儿童肺结核诊断专家共识. 中国实用儿科杂志, 2022, 37(7):490-496. doi:10.3760/cma.j.cn101070-2021207-01436. doi: 10.3760/cma.j.cn101070-2021207-01436
[5]	World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis 2016 update. Geneva: World Health Organization, 2016.
[6]	中国防痨协会. 耐药结核病化学治疗指南(2019年简版). 中国防痨杂志, 2019, 41(10): 1025-1073. doi:10.3969/j.issn.1000-6621.2019.10.001. doi: 10.3969/j.issn.1000-6621.2019.10.001
[7]	World Health Organization. WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment-Drug-Resistant Tuberculosis Treatment. Geneva: World Health Organization, 2020.
[8]	何晋月, 方青, 罗飞, 等. 单纯后路开放手术治疗儿童胸、腰椎结核的临床疗效. 陆军军医大学学报, 2022, 44(17):1752-1756. doi:10.16016/j.2097-0927.202202114. doi: 10.16016/j.2097-0927.202202114
[9]	修鹏, 宋跃明, 李涛, 等. 儿童期起病腰骶结核手术治疗的临床疗效. 中国脊柱脊髓杂志, 2022, 32(8):676-679. doi:10.3969/j.issn.1004-406X.2022.08.01. doi: 10.3969/j.issn.1004-406X.2022.08.01
[10]	Kirkmall MA, Sfidhar K. Posterior listhesis of a lumbar vertebra in spinal tuberculosis. Eur Spine J, 2011, 20(1):1-5.doi:10.1128/AAC.05429-11. doi: 10.1007/s00586-010-1524-5 pmid: 20689971
[11]	孔祥霖, 沈生军. 儿童胸腰椎结核的诊治现状. 临床医学进展, 2022, 12(6):5983-5989. doi:10.3969/j.issn.1672-2957.2018.04.013. doi: 10.3969/j.issn.1672-2957.2018.04.013
[12]	牛建雄, 张同同, 薛文, 等. 儿童胸椎化脓性脊柱炎误诊为脊柱结核一例. 中国骨伤, 2022, 35(10):1008-1010. doi:10.12200/j.issn.1003-0034.2022.10.020. doi: 10.12200/j.issn.1003-0034.2022.10.020
[13]	范天奇, 尹华斌, 宋滇文, 等. 儿童脊柱结核治疗现状及进展. 脊柱外科杂志, 2018, 16(4):248-251. doi:10.3969/j.issn.1672-2957.2018.04.013. doi: 10.3969/j.issn.1672-2957.2018.04.013
[14]	中华医学会结核病学分会. 中国耐多药和利福平耐药结核病治疗专家共识(2019年版). 中华结核和呼吸杂志, 2019, 42(10):733-749. doi:10.3760/cma.j.issn.1001-0939.2019.10.006. doi: 10.3760/cma.j.issn.1001-0939.2019.10.006
[15]	Schulitz KP, Kothe R, Leong JC, et al. Growth changes of solidly fused kyphoticbloc after surgery for mberculosis:a comparison of four procedures. Spine, 1997, 22:1150-1155.doi:10.1517/17425255.2016.1162785. doi: 10.1517/17425255.2016.1162785 pmid: 9160475
[16]	中华医学会结核病学分会,抗结核药物超说明书用法专家共识编写组. 抗结核药物超说明书用法专家共识. 中华结核和呼吸杂志, 2018, 41(6):447-460. doi:10.3760/cma.j.issn.1001-0939.2018.06.006. doi: 10.3760/cma.j.issn.1001-0939.2018.06.006
[17]	World Health Organization. Rapid communication: key changes to treatment of multidrug-and rifampicin-resistant tuberculosis (MDR/RR-TB). Geneva: World Health Organization, 2018.
[18]	白云松, 张学军, 曹隽, 等. 一期前后路联合手术治疗儿童腰椎结核的临床疗效分析. 中国防痨杂志, 2020, 42(10):1048-1052. doi:10.3969/j.issn.1000-6621.2020.10.008. doi: 10.3969/j.issn.1000-6621.2020.10.008
[19]	赵明伟, 杨素珉, 周伟东, 等. 后路长节段固定、前路病灶清除短节段融合在多节段胸腰椎结核手术中的应用. 中国防痨杂志, 2017, 39(4):353-357. doi:10.3969/j.issn.1000-6621.2017.04.009. doi: 10.3969/j.issn.1000-6621.2017.04.009

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 5

References 19

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Yan Wenhua, Chen Wenjun. The value of digital health education in the preventive management of caregivers of patients with bacterial positive pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 73-78.
[2]	Gu Jinhua, Zhang Panpan. Evaluation of the application value of three detection methods for Mycobacterium tuberculosis in a comprehensive hospital [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 68-72.
[3]	Qi Wei, Zhao Enyi. The epidemic characteristics and the trends of pulmonary tuberculosis in elderly and non-elderly in central urban area, Tianjin from 2006 to 2020 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 46-54.
[4]	Zheng Jianli, Wu Yumei, Zhang Shili, Du Zixian, Li Turong, Chen Shisheng, Lin Wenge. Cost-effectiveness analysis of active tuberculosis screening among high-risk populations in Longyan City, Fujian Province [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 35-39.
[5]	Zhao Yongnian, Zhang Lijie, Wang Tongmin. Analysis of the epidemiological characteristics of reported pulmonary tuberculosis in Xinjiang Production and Construction Corps, 2014—2023 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 30-34.
[6]	Chen Jing, Qin Yali, Wang Mingdong, Yang Rubin, Wang Qian, Peng Yanqing, Qiu Jiyao, Zhang Xiao, Zhou Xinai. The value of QuantiFERON-TB Gold Plus in the clinical diagnosis of active pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 61-67.
[7]	Liao Ying, Pang Yan, Zhao Jing, He Gaoqin, You Maolin, Wang Lei. Analysis on the reporting and case finding delay characteristics of pulmonary tuberculosis patients in Liangping District, Chongqing from 2018 to 2023 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 8-13.
[8]	. [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 495-499.
[9]	Liu Fang, Ma Jintong, Liu Yongmei, Luo Peipei, Feng Yang, Liu Zhenlong, Wang Yuhong. Analysis of risk factors of chronic obstructive pulmonary disease complicated with pulmonary tuberculosis with tendency score matching method and construction of a prediction model [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 511-516.
[10]	Ma Xiaoling, Zhao Yongnian, Duan Lili, Liu Xinwen. Construction and validation of a nomogram model for predicting adverse outcomes of pulmonary tuberculosis patients in 2016—2022 in Xinjiang Production and Construction Corps [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 552-559.
[11]	Fan Weifang, Huang Jinpeng, Yao Liwei. Advances in pulmonary rehabilitation nursing for patients with post-tuberculosis lung Disease [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 560-566.
[12]	Sun Huijuan, Su Wei, Chen Wei. Research progress on unfavourable treatment outcomes and risk factors of rifampicin-resistant tuberculosis patients [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 573-582.
[13]	Cai Xiaoting, Du Yuhua, Wu Guifeng, He Liqian, Su Bihui, Gong Fang, Wang Ting, Lai Keng, Wu Xiaoying. Analysis of pulmonary tuberculosis registration and its characteristics in Guangzhou City from 2016 to 2023 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(5): 430-436.
[14]	Sun Bo, Feng Liping, Teng Chong, Zhu Hanfang, Zhao Bing, Feng Tao, Wang Qingkui, Zhou Hao, Gao Xinghai, Ou Xichao. Analysis of features of drug resistance of Mycobacterium tuberculosis and risk factors of multidrug-resistance in Hinggan League of Inner Mongolia Autonomous Region, 2021—2023 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(5): 437-444.
[15]	. [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(4): 376-378.